TY  - GEN
TI  - $675 million for MRSA antibiotic
SN  - 1546-1696
PY  - 2016///0211
KW  - Drug Industry
KW  - economics
KW  - Humans
KW  - Methicillin-Resistant Staphylococcus aureus
KW  - drug effects
KW  - Staphylococcal Skin Infections
KW  - drug therapy
KW  - Teicoplanin
KW  - analogs & derivatives
N1  - Publication Type: News
UR  - https://doi.org/10.1038/nbt1114-1070c
ER  -